Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Group: Glucagon_Like_Peptide_1_GLP_1_receptor_agonists85394_C_85798

Generated Narrative: Group 236776

version: 60; Last updated: 2024-10-03 13:11:20+0000

Profile: ExposureDefinition

Artifact Author: Computable Publishing®: MAGIC-to-FEvIR Converter:

Artifact related artifact: No display for RelatedArtifact (type: part-of; resourceReference: ->display: string (PrimitiveType/Group.extension[1].value[x].resourceReference.display): element = string -> display=string[MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes])

Artifact Title: ComparatorDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists

Artifact URL: https://fevir.net/resources/Group/236776

Artifact Publisher: Computable Publishing LLC

Artifact Copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

Artifact use context: Evidence Communication = ExposureDefinition

Artifact Contact: support@computablepublishing.com

Artifact Status: active

identifier: FEvIR Object Identifier/236776, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-comparator-85394-C-85798

name: Glucagon_Like_Peptide_1_GLP_1_receptor_agonists85394_C_85798

description:

This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.

type: Animal

membership: Definitional